Published in Health and Medicine Week, November 22nd, 2010
"Although peripheral giant cell granulomas is a well-described clinical entity, little is known on its pathogenesis. The aim of this study was to investigate the receptor activator of NF-kappa B ligand (RANKL) and osteoprotegerin (OPG) expression and immunolocalization in giant cell granulomas. RANKL and OPG protein expression was evaluated in 22 peripheral giant cell granulomas samples, by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week